ArticleExperimental and therapeutic medicine2016

Efficacy, safety and administration timing of trastuzumab in human epidermal growth factor receptor 2 positive breast cancer patients: A meta-analysis.

Yuan-Yuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.